Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling

PURPOSE: Apatinib is an inhibitor of VEGFR2 (vascular endothelial growth factor receptor 2) that has attracted a great deal of attention due to its promotion of anticancer activity. In the present study, we investigated the therapeutic effects of apatinib against colorectal cancer (CRC) and examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiaomin, Wei, Bin, Li, Lele, Chen, Xiaofeng, Yang, Jing, Li, Xiaofei, Jiang, Xiaozheng, Lv, Mu, Li, Mingyang, Lin, Yumeng, Xu, Qiang, Guo, Wenjie, Gu, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606303/
https://www.ncbi.nlm.nih.gov/pubmed/33154652
http://dx.doi.org/10.2147/OTT.S266549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606303/
https://www.ncbi.nlm.nih.gov/pubmed/33154652
http://dx.doi.org/10.2147/OTT.S266549

Ejemplares similares